Agent Affecting Bone Metabolism

Oledron 4mg / 5ml
Pamidronate Disodium 3mg/ml injection

Composition: Zoledronic acid anhydrous 4mg.
Indication: Prevention of skeletal related events pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced (hypercalcaemia) in patients with advanced malignancies involving bone. Treatment of hypercalcemia of malignancy (HCM).
Packing: 5ml vial

Composition: Pamidronate Disodium 3mg/ml.
Indication: Treatment of conditions associated with increased osteoclast activity: Predominantly lytic bone metastases and multiple myeloma; tumour-induced hypercalcaemia; Paget’s disease of bone.
Packing: 1 x 10ml vial